Jul 30, 2026 04:01PM
Jul 22, 2026 08:31AM
Jul 22, 2026 08:30AM
Jul 16, 2026 08:30AM
Jun 11, 2026 08:30AM
Jun 11, 2026 08:30AM
May 29, 2026 08:15AM Tempus receives FDA approval for tumor-only xT CDx genomic test
May 29, 2026 08:15AM
May 11, 2026 08:30AM
Apr 28, 2026 08:30AM
Apr 23, 2026 11:45AM
Apr 13, 2026 08:30AM
Mar 10, 2026 07:21AM
Feb 18, 2026 11:45AM FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
Feb 12, 2026 04:05PM
Feb 12, 2026 04:05PM
Jan 27, 2026 08:33AM
Jan 27, 2026 08:30AM
Nov 5, 2025 01:52AM
Nov 4, 2025 04:01PM
Oct 1, 2025 12:24PM Ambry Genetics enhances breast cancer risk assessment tool with breast density
Oct 1, 2025 12:24PM
Sep 22, 2025 08:30AM
Sep 22, 2025 08:30AM
Sep 15, 2025 08:01AM
Sep 15, 2025 08:00AM
Sep 12, 2025 06:44AM
Sep 11, 2025 08:30AM Tempus receives FDA clearance for updated cardiac imaging device
Sep 11, 2025 08:30AM
Aug 22, 2025 09:20AM
Aug 22, 2025 09:20AM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
May 20, 2025 08:33AM
May 20, 2025 08:30AM Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment
May 12, 2025 08:45AM
Apr 29, 2025 08:45AM
Apr 16, 2025 08:45AM
Mar 25, 2025 08:45AM
Mar 10, 2025 09:16AM
Feb 24, 2025 04:01PM
Feb 11, 2025 08:45AM Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
Jan 16, 2025 08:45AM
Jan 15, 2025 08:32AM
Jan 15, 2025 08:30AM
Dec 17, 2024 08:45AM
Dec 17, 2024 08:30AM
Dec 4, 2024 08:45AM
Sep 13, 2024 08:30AM Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024
Aug 8, 2024 08:30AM

327,801 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All